H.R.3082

Evidence-Based Drug Policy Act of 2025

Introduced·4/29/25

Evidence-Based Drug Policy Act of 2025 repeals section 704(b)(12) of the Office of National Drug Control Policy Reauthorization Act of 1998.

The Evidence-Based Drug Policy Act of 2025 repeals section 704(b)(12) of the Office of National Drug Control Policy Reauthorization Act of 1998. This section previously required the Office of National Drug Control Policy to prioritize funding for drug demand reduction programs based on scientific evidence. The bill aims to remove this requirement, potentially affecting how drug demand reduction programs are funded and prioritized.

Included in complete analysis

  • Overview
  • Core Provisions
  • Implementation
  • Impact
  • Legal Framework
  • Critical Issues

See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.

Where it stands

Current
Oversight And Government Reform Committee
Next
Committee decision

Sponsors

3
0
Democratic CaucusRepublican Caucus

History

Apr 29, 2025

House

Introduced in House

Apr 29, 2025

House

Referred to the Committee on Oversight and Government Reform, and in addition to the Committees on Energy and Commerce, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.